醫藥和生技產業共同促銷與共同行銷（2016-2026年）

醫藥和生物技術領域的共同促銷和共同行銷協議。

讓我們了解一下製藥和生物技術公司是如何建立、談判和實施共同促銷和共同行銷夥伴關係的。

《醫藥和生物技術產業的共同促銷和共同行銷》提供了有關在生命科學領域達成聯合商業化協議的全面資訊。

本報告涵蓋了 523 項公開揭露的共同促銷和共同行銷協議，詳細分析了各公司如何利用聯合商業化夥伴關係進入市場、整合商業性功能並最大限度地提高其醫藥和生物技術資產的價值。

這份報告不僅僅是列出交易；它還允許用戶查看哪些公司正在合作，交易是如何構建的，哪些資產和治療領域正在吸引檢驗，以及可以從公開的交易條款和合約文件中了解到什麼。

本報告旨在為參與評估和談判共同商業化機會的業務發展、許可、商業策略、合作夥伴關係管理和法律團隊提供可操作的資訊來源和基準。

了解共同促銷和共同行銷交易的趨勢。

本報告分析了2016年至2026年的交易趨勢，內容包括：

• 共同促銷和共同行銷協議的年度趨勢
• 合作關係建立時的發展階段
• 產業部門
• 治療區域
• 技術類型
• 最活躍的交易實體
• 根據已揭露的交易金額，主要交易金額
• 簽訂聯合銷售和共同行銷協議的策略原因
• 與聯合商業化相關的交易趨勢
• 這使用戶能夠了解活動集中在哪些地方，哪些公司正在積極利用這些機制，以及整個產業的合作策略有何不同。
• 交易結構和商業條件的基準分析
• 共同促銷和共同行銷協議在商業責任、銷售區域、權利和經濟條款方面可能存在顯著差異。

本報告提供以下領域的信息，以幫助使用者了解並進行基準測試：

• 負責推廣和商業化
• 與該地區和市場相關的權利
• 獨家合約
• 收入和利潤分享機制
• 製造和供應方面的職責
• 合約期限和終止條款
• 轉讓和分包權利
• 管治和營運職責
• 如已揭露，財務狀況如下：
• 對於準備進行交易的公司而言，這可以作為有價值的參考資料，用於確定類似的夥伴關係是如何建立的。
• 從實際合約中學習
• 本報告的主要內容是盡可能取得公開的合約文件。
• 這些協議提供了公司公告中通常披露的資訊之外的見解，使用戶能夠仔細審查管理特定共同促銷和共同行銷夥伴關係的詳細條款。
• 透過利用合約訊息，使用者可以了解每家公司如何處理諸如授予權利、收入分成、商業化義務、獨家經營權、生產製造、合約終止、保密、爭議解決和其他協商條款等問題。
• 識別主要交易商和交易
• 本報告列出了 25 位共同促銷和共同行銷領域最活躍的交易商，並根據揭露的交易額檢驗了他們的主要交易。
• 這樣可以更清楚地了解哪些公司正在積極推行聯合商業化策略，使用戶能夠更深入地調查這些公司的交易活動。
• 綜合交易目錄
• 本報告收錄了 2016 年至 2026 年間宣布的共同促銷和共同行銷交易的完整目錄。

交易記錄可依以下標準查看：

• 公司
• 治療區域
• 技術類型
• 合約揭露狀態
• 每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊以及（如有）相關的合約文件。
• 這份報告適合哪些讀者？

本報告對以下部門特別有用：

• 業務拓展與授權團隊
• 它可用於對類似交易進行基準測試、識別活躍合作夥伴，並協助進行交易準備和談判。
• 商業策略團隊
• 我們將了解各公司如何共享商業化權利、能力、銷售區域和責任。
• 聯盟管理團隊
• 這將檢驗現有的合作商業化夥伴關係是如何建立和管理的。
• 法律與合約團隊
• 我們將審查實際的合約條款，並對每筆交易的合約方式進行比較和考慮。
• 企業策略與經營團隊
• 我們評估共同促銷和共同行銷活動、主要參與者以及不斷發展的合作夥伴關係策略。
• 我們將市場資訊轉化為針對貴公司的專屬洞察。
• 符合資格的客戶除了收到 Current Partnering 的報告外，還將收到一份客製化的「高階主管合作夥伴簡報」。
• 本簡報將說明如何將基礎交易資訊應用於您自己的業務、資產、技術、目標市場或合作目標。
• 如有需要，我們可以提供相關的類似交易、有前景的潛在合作夥伴、交易結構、財務基準、合約見解以及其他專門挑選的、適合您合作情況的資訊。
• 請索取樣本或聯絡 Current Partnering 討論本報告的內容以及我們是否可以為貴公司提供客製化分析。

目錄

執行摘要

第1章：引言

第2章：共同促銷與共同行銷交易的趨勢

• 介紹
• 共同促銷和共同行銷協議的定義
• 共同促銷和共同行銷協議的發展趨勢
• 簽訂共同促銷和共同行銷夥伴關係協議的原因
• 共同促銷和共同行銷協議的未來

第3章：共同促銷與共同行銷協議架構概述

• 介紹
• 共同促銷和共同行銷協議的結構

第4章：共同促銷與共同行銷舉措

• 介紹
• 以金額為準的頂級共同促銷和共同行銷交易

第5章：共同促銷與共同行銷交易最活躍的25家公司

• 介紹
• 共同促銷和共同行銷。

第6章：共同促銷和共同行銷協議（包括協議清單）

• 介紹
• 共同促銷和共同行銷協議
• 特價優惠列表
• 交易目錄 - AZ 提供的公司特定共同促銷和共同行銷交易
• 交易目錄 - 按治療領域分類的共同促銷和共同行銷交易
• 交易目錄 - 按技術類型分類的共同促銷和共同行銷交易
• 關於 Biopharma Research Ltd.
• Current Partnering
• 目前合約
• 理想合作夥伴最新報告的標題

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology

Understand how pharmaceutical and biotechnology companies structure, negotiate and implement co-promotion and co-marketing partnerships.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive intelligence on co-commercialization dealmaking across the life sciences sector.

The report brings together 523 announced co-promotion and co-marketing deals, providing detailed analysis of how companies are using shared commercialization partnerships to access markets, combine commercial capabilities and maximize the value of pharmaceutical and biotechnology assets.

Rather than simply identifying transactions, the report enables users to examine who is partnering, how deals are structured, which assets and therapeutic areas are attracting activity, and what can be learned from publicly available deal terms and contract documents.

It is designed as a practical intelligence and benchmarking resource for business development, licensing, commercial strategy, alliance management and legal teams involved in evaluating or negotiating co-commercialization opportunities.

Understand the co-promotion and co-marketing deal landscape

The report analyzes deal activity from 2016 to 2026, including:

• Trends in co-promotion and co-marketing dealmaking by year
• Stage of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering co-promotion and co-marketing agreements
• How co-commercialization dealmaking is evolving
• This enables users to identify where activity is concentrated, which companies are actively using these structures and how partnering strategies differ across the industry.
• Benchmark deal structures and commercial terms
• Co-promotion and co-marketing agreements can vary significantly in the allocation of commercial responsibilities, territories, rights and economics.

The report provides intelligence to help users understand and benchmark areas including:

• Promotion and commercialization responsibilities
• Geographic and market rights
• Exclusivity arrangements
• Revenue and profit-sharing mechanisms
• Manufacturing and supply responsibilities
• Term and termination provisions
• Sublicensing and subcontracting rights
• Governance and operational responsibilities
• Financial terms where disclosed
• For companies preparing for a transaction, this provides valuable reference points for determining how comparable partnerships have been structured.
• Learn from real-world contracts
• A major component of the report is access to publicly available contract documents where available.
• These agreements provide insight beyond the information normally disclosed in company announcements, allowing users to examine the detailed provisions governing selected co-promotion and co-marketing partnerships.
• Contract intelligence can help users understand how companies have addressed issues such as rights granted, revenue sharing, commercialization obligations, exclusivity, manufacturing, termination, confidentiality, dispute resolution and other negotiated provisions.
• Identify leading dealmakers and transactions
• The report identifies the Top 25 most active co-promotion and co-marketing dealmakers and examines leading transactions by disclosed deal value.
• This provides a clear view of the companies most actively pursuing shared commercialization strategies and enables users to investigate their deal activity in greater depth.
• Comprehensive deal directory
• The report includes a comprehensive directory of co-promotion and co-marketing deals announced from 2016 to 2026.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Each transaction is linked to its underlying deal record, providing a route to further deal information and, where available, associated contract documentation.
• Who should use this report?

The report is particularly relevant to:

• Business Development and Licensing teams
• Benchmark comparable transactions, identify active partners and support deal preparation and negotiation.
• Commercial Strategy teams
• Understand how companies share commercialization rights, capabilities, territories and responsibilities.
• Alliance Management teams
• Examine how existing co-commercialization partnerships have been structured and governed.
• Legal and Contracts teams
• Review real agreement language and compare contractual approaches across transactions.
• Corporate Strategy and Senior Management
• Assess co-promotion and co-marketing activity, leading participants and evolving partnering strategies.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing takes the underlying deal intelligence and applies it to the customer's own business, assets, technologies, target markets or partnering objectives.
• Depending on requirements, this can include identification of relevant comparable deals, prospective partners, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's partnering situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals
  • 2.3.1. Co-promotion and co-marketing dealmaking by year
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development
• Figure 4: Co-promotion and co-marketing deals by industry sector
• Figure 5: Co-promotion and co-marketing deals by therapy area
• Figure 6: Co-promotion and co-marketing deals by technology type
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers
• Figure 8: Top co-promotion and co-marketing deals by value
• Figure 9: Most active co-promotion and co-marketing dealmakers